StockData
Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc (TNDM) stock

TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3024% below fair value
$17.06−1.42 (-7.68%)

Close on Nov 17, 2026Market cap $1.19BP/E –Yield –

Tandem Diabetes Care gross margin

Gross margin is gross profit as a percentage of revenue.

Tandem Diabetes Care's gross margin for the twelve months ending Jun 30, 2026 was 56.0%. For fiscal 2025 it was 53.8%, against 52.1% the year before. The highest annual figure on record is 53.8% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202553.8%+1.7
FY2024Dec 31, 202452.1%+2.9
FY2023Dec 31, 202349.2%−2.4
FY2022Dec 31, 202251.5%−2.0
FY2021Dec 31, 202153.5%+1.3
FY2020Dec 31, 202052.2%−1.4
FY2019Dec 31, 201953.6%+4.8
FY2018Dec 31, 201848.9%+7.9
FY2017Dec 31, 201741.0%+13.0
FY2016Dec 31, 201628.0%−8.5
FY2015Dec 31, 201536.5%+5.8
FY2014Dec 31, 201430.7%+9.4
FY2013Dec 31, 201321.3%+75.7
FY2012Dec 31, 2012-54.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202656.9%+4.6
Q1 FY2026Mar 31, 202655.3%+4.8
Q4 FY2025Dec 31, 202557.7%+2.0
Q3 FY2025Sep 30, 202553.9%+2.8
Q2 FY2025Jun 30, 202552.3%+1.5
Q1 FY2025Mar 31, 202550.5%+1.1
Q4 FY2024Dec 31, 202455.7%+8.3
Q3 FY2024Sep 30, 202451.1%+2.7
Q2 FY2024Jun 30, 202450.8%−1.1
Q1 FY2024Mar 31, 202449.4%+0.4
Q4 FY2023Dec 31, 202347.4%−5.0
Q3 FY2023Sep 30, 202348.4%−2.7
Q2 FY2023Jun 30, 202351.9%+1.0
Q1 FY2023Mar 31, 202348.9%−2.8
Q4 FY2022Dec 31, 202252.4%−1.8
Q3 FY2022Sep 30, 202251.1%−2.8
Q2 FY2022Jun 30, 202250.9%−2.8
Q1 FY2022Mar 31, 202251.8%−0.2
Q4 FY2021Dec 31, 202154.2%+0.3
Q3 FY2021Sep 30, 202153.9%+1.0
Q2 FY2021Jun 30, 202153.7%+3.9
Q1 FY2021Mar 31, 202152.0%+0.6
Q4 FY2020Dec 31, 202053.9%−1.7
Q3 FY2020Sep 30, 202052.8%−0.7
Q2 FY2020Jun 30, 202049.8%−3.7
Q1 FY2020Mar 31, 202051.3%+0.8
Q4 FY2019Dec 31, 201955.6%+1.1
Q3 FY2019Sep 30, 201953.5%+6.4
Q2 FY2019Jun 30, 201953.5%+9.3
Q1 FY2019Mar 31, 201950.5%+8.7
Q4 FY2018Dec 31, 201854.5%+11.2
Q3 FY2018Sep 30, 201847.1%+3.1
Q2 FY2018Jun 30, 201844.2%+6.7
Q1 FY2018Mar 31, 201841.8%+6.2
Q4 FY2017Dec 31, 201743.4%+8.5
Q3 FY2017Sep 30, 201744.0%+56.8
Q2 FY2017Jun 30, 201737.5%–
Q1 FY2017Mar 31, 201735.6%–
Q4 FY2016Dec 31, 201634.8%–
Q3 FY2016Sep 30, 2016-12.8%–

More Tandem Diabetes Care figures

See a number that looks wrong?